Clinical trial
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
NCT02943590
Study timeline
Study start (actual)2017-01-13Date precision: day
Registry last updated2025-05-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureverified · MONDO: heart failure
Interventions
PlaceboDRUG
AtorvastatinDRUG · verified · RxNorm: atorvastatin
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
Dana-Farber Cancer Institutecollaborator
Brigham and Women's Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02943590 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.